Chelation Therapy

Displaying 1 - 3 of 3CSV
Lamas, G. A., Anstrom, K. J., Navas-Acien, A., Boineau, R., Nemeth, H., Huang, Z., Wen, J., Rosenberg, Y., Stylianou, M., Jones, T. L. Z., Joubert, B. R., Yu, Q., Santella, R. M., Mon, A. C., Ujueta, F., Escolar, E., Nathan, D. M., Fonseca, V. A., Aude, Y. W., … Acevedo, B. (2024). Edetate Disodium–Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes. JAMA, 332(10), 794. https://doi.org/10.1001/jama.2024.11463
Publication Date
Navas-Acien, A., Santella, R. M., Joubert, B. R., Huang, Z., Lokhnygina, Y., Ujueta, F., Gurvich, I., LoIacono, N. J., Ravalli, F., Ward, C. D., Jarrett, J. M., Salazar, A. D. L., Boineau, R., Jones, T. L. Z., Mark, D. B., Newman, J. D., Nathan, D. M., Anstrom, K. J., & Lamas, G. A. (2024). Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2). American Heart Journal, 273, 72–82. https://doi.org/10.1016/j.ahj.2024.04.005
Publication Date
Ravalli, F., Vela Parada, X., Ujueta, F., Pinotti, R., Anstrom, K. J., Lamas, G. A., & Navas‐Acien, A. (2022). Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review. Journal of the American Heart Association, 11(6). https://doi.org/10.1161/jaha.121.024648
Publication Date